In contrast to the transgelin-1, in many studies, transgelin-2 expression was proposed as a potential cancer biomarker (Zhang et al., 2010; Dvorakova et al., 2014; Meng et al., 2017; Yin et al., 2019). This evidence concerns the gene TAGLN2 and cancer.